| Weight | 0,05 kg |
|---|
ARA-290 10mg
Research Grade Peptide
- Research Grade
- 99% Purity
- Third-Party Verified
Reference Strength: 10mg
R569,00
CAS: 1208243-50-8
Formula: 1208243-50-8
Molecular Weight: 1257.3 g/mol
Chemical Name / Amino Acid Sequence: pGlu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-NH2
Availability: In stock
SKU: RA10
R569,00
ARA-290 (Cibinetide) is an erythropoietin-derived peptide investigated for its tissue-protective, anti-inflammatory and neuroprotective properties.
Availability: In stock
Included with your purchase
Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.
Complimentary Purchase Kit
Every qualifying vial includes a complimentary purchase kit at no additional cost.
Research Overview
About ARA-290 10mg
ARA-290 is an 11-amino acid peptide derived from the helix-B domain of erythropoietin. It selectively activates the Innate Repair Receptor (IRR) without stimulating red blood cell production, making it a focus of research into neuropathy, tissue repair and inflammation.
How It Works in Research
Researchers study ARA-290 for its potential to support tissue repair and reduce inflammation while avoiding the erythropoietic effects associated with erythropoietin.
Research Applications
Peripheral neuropathy Small-fiber neuropathy Tissue repair Neuroprotection Inflammation research Pain modulation
ARA-290 binds the Innate Repair Receptor (EPOR/CD131 heterodimer), activating anti-inflammatory and anti-apoptotic signalling pathways that promote tissue repair without increasing red blood cell production.
Key Benefits
- Neuroprotection research
- Tissue protection studies
- Anti-inflammatory activity
- Nerve regeneration research
- Pain-modulation investigations
Product Specifications
- Product Name: ARA-290
- Alternate Chemical Name: Cibinetide (HBSP)
- Reference Strength: 10mg
- Purity Standard: ≥98% (HPLC)
- Appearance: White to off-white lyophilised powder
- Category: Tissue-Protective Peptide
Research Information
- CAS Number: 1208243-50-8
- Molecular Formula: C51H84N16O21
- Molecular Weight: 1257.3 g/mol
- Storage: 2–8°C after reconstitution
- Sequence: pGlu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-NH2
Mechanism of Action
ARA-290 binds the Innate Repair Receptor (EPOR/CD131 heterodimer), activating anti-inflammatory and anti-apoptotic signalling pathways that promote tissue repair without increasing red blood cell production.
Key Research Characteristics
Erythropoietin-derived peptide
Selective Innate Repair Receptor (IRR) agonist Non-erythropoietic Investigated in neuropathy and tissue repair research Designed for daily research protocols
Potential Benefits in Research
Neuroprotection research
- Tissue protection studies
- Anti-inflammatory activity
- Nerve regeneration research
- Pain-modulation investigations
Safety Profile
Clinical studies have generally reported good tolerability. Mild injection-site reactions may occur. Long-term safety continues to be evaluated.
Research Applications
Peripheral neuropathy
Small-fiber neuropathy
Tissue repair
Neuroprotection
Inflammation research
Pain modulation
For Research Purposes Only.
This product is intended strictly for laboratory and scientific research applications. It is not intended for human consumption or for the diagnosis, treatment, cure or prevention of any disease.
REFERENCE RECONSTITUTION INFORMATION
ARA-290 is supplied as a lyophilised peptide and should be reconstituted using bacteriostatic water before laboratory research use.
Always follow sterile preparation techniques when handling research peptides.
The following preparation information is provided for laboratory research purposes only.
General Preparation
Store refrigerated after reconstitution and use within 28 days. Do not freeze after reconstitution.
- Draw 2.0 mL bacteriostatic water, inject slowly down the vial wall, gently swirl until fully dissolved, label with the preparation date and refrigerate at 2–8°C.
Reconstitution: Add 2.0 mL bacteriostatic water to a 10 mg vial. Final Concentration: 5 mg/mL
Reference Handling Information
Reference information for laboratory handling of ARA-290 10mg.
- Use a new sterile syringe for each preparation.
- Rotate injection sites during research protocols.
- Record preparation dates and usage.
- Discard the solution if it becomes cloudy or discoloured.
Reference Parameters (Week|Daily Dose|Units (U-100)|Volume)
| Week 1 | 2mg | 40 Units | 0.40ml |
|---|---|---|---|
| Weeks 2–5 | 4mg | 80 Units | 0.80ml |
For laboratory research only.
Experimental Study Period
STUDY PERIOD
4–8 weeks
RESEARCH CONTEXT
Support tissue protection, anti-inflammatory signalling and neuropathic symptom management in laboratory research.
View Certificate of Analysis
View Certificate of Analysis Each batch of ARA-290 is independently tested by third-party laboratories. Download the Certificate of Analysis to verify purity, identity, and quality.
99.6%
Verified Purity
3rd Party
Lab Tested
Certified
Quality Assured
Related products
PURE PERFORMANCE LABS
Recommended Research Products
Explore related compounds commonly viewed alongside this product.
FOR RESEARCH PURPOSES ONLY
This product is intended for research and laboratory use only. Always consult qualified researchers and follow appropriate safety protocols.